Panagora Asset Management’s PRA Health Sciences, Inc. PRAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-2,374
| Closed | -$392K | – | 2841 |
|
|
2021
Q2 | $392K | Sell |
2,374
-230
| -9% | -$38.4K | ﹤0.01% | 1421 |
|
|
2021
Q1 | $399K | Buy |
2,604
+1,396
| +116% | +$190K | ﹤0.01% | 1441 |
|
|
2020
Q4 | $152K | Buy |
1,208
+149
| +14% | +$16.7K | ﹤0.01% | 1697 |
|
|
2020
Q3 | $107K | Hold |
1,059
| – | – | ﹤0.01% | 1770 |
|
|
2020
Q2 | $103K | Hold |
1,059
| – | – | ﹤0.01% | 1780 |
|
|
2020
Q1 | $88K | Sell |
1,059
-191
| -15% | -$18.6K | ﹤0.01% | 1735 |
|
|
2019
Q4 | $139K | Sell |
1,250
-9,669
| -89% | -$995K | ﹤0.01% | 1722 |
|
|
2019
Q3 | $1.08M | Sell |
10,919
-38,564
| -78% | -$3.83M | 0.01% | 979 |
|
|
2019
Q2 | $4.91M | Buy |
49,483
+19,142
| +63% | +$1.83M | 0.02% | 508 |
|
|
2019
Q1 | $3.35M | Buy |
30,341
+28,483
| +1,533% | +$2.98M | 0.01% | 647 |
|
|
2018
Q4 | $171K | Sell |
1,858
-4,559
| -71% | -$461K | ﹤0.01% | 1675 |
|
|
2018
Q3 | $707K | Sell |
6,417
-153,997
| -96% | -$16M | ﹤0.01% | 1266 |
|
|
2018
Q2 | $15M | Sell |
160,414
-202,920
| -56% | -$17.5M | 0.06% | 268 |
|
|
2018
Q1 | $30.1M | Sell |
363,334
-113,041
| -24% | -$10M | 0.12% | 173 |
|
|
2017
Q4 | $43.4M | Sell |
476,375
-29,738
| -6% | -$2.47M | 0.16% | 145 |
|
|
2017
Q3 | $38.6M | Buy |
506,113
+241,291
| +91% | +$18.2M | 0.15% | 147 |
|
|
2017
Q2 | $19.9M | Buy |
264,822
+60,877
| +30% | +$4.22M | 0.08% | 254 |
|
|
2017
Q1 | $13.3M | Buy |
203,945
+85,601
| +72% | +$5.04M | 0.06% | 345 |
|
|
2016
Q4 | $6.52M | Buy |
118,344
+14,484
| +14% | +$795K | 0.03% | 481 |
|
|
2016
Q3 | $5.87M | Buy |
103,860
+47,410
| +84% | +$2.32M | 0.03% | 509 |
|
|
2016
Q2 | $2.36M | Sell |
56,450
-743
| -1% | -$34.2K | 0.01% | 809 |
|
|
2016
Q1 | $2.45M | Sell |
57,193
-5,311
| -8% | -$224K | 0.01% | 806 |
|
|
2015
Q4 | $2.83M | Buy |
62,504
+60,894
| +3,782% | +$2.56M | 0.01% | 699 |
|
|
2015
Q3 | $63K | Sell |
1,610
-96
| -6% | -$3.84K | ﹤0.01% | 1936 |
|
|
2015
Q2 | $62K | Buy |
+1,706
| New | +$54K | ﹤0.01% | 2092 |
|
Other funds holding PRAH
Panagora Asset Management's PRAH Position: Q3 2021 in Review
Panagora Asset Management sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 2,374 shares — an estimated $392K sold.
Panagora Asset Management first reported a position in PRAH in Q2 2015 and held it in 25 quarters. The position peaked at $43.4M in Q4 2017. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.
- Panagora Asset Management reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
- Panagora Asset Management sold 2,374 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $392K.
- Panagora Asset Management first reported a position in PRA Health Sciences, Inc. in Q2 2015 and held it in 25 quarters.
- Panagora Asset Management's PRA Health Sciences, Inc. position peaked at $43.4M in Q4 2017.
- 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.
Based on Panagora Asset Management's 13F filing for Q3 2021, filed 10 Nov 2021.